Everstack Evidence

Omega-3 and heart outcomes: why the big trials disagree

Large trials with mixed results depending on dose, formulation, population and placebo choice.

Published 2026-10-15Sources checked 2026-10-153 sourcesEverstack research teamHow we work

Editorial section. Research summaries are not product claims and contain no product links or offers. A summary is never proof that any product works.

The question

Do omega-3 supplements reduce major cardiovascular events?

Study design

Three large randomized trials: VITAL (1 g per day fish oil, 25,871 healthy adults), REDUCE-IT (4 g per day purified EPA, high-risk patients on statins) and STRENGTH (4 g per day EPA plus DHA vs corn oil, high-risk patients). ^[1][2][3]

What they found

VITAL found no reduction in the primary composite of major cardiovascular events. REDUCE-IT reported a large reduction with a prescription EPA drug. STRENGTH found no benefit. Researchers still debate whether REDUCE-IT's mineral oil placebo inflated the difference. ^[1][2][3]

Limitations

REDUCE-IT and STRENGTH tested prescription doses in patients, not supplements in healthy people.

What this does not mean

Omega-3 supplements are not a substitute for prescribed heart care.

Sources

1. Manson JE et al. N Engl J Med. 2019;380:23-32. doi.org/10.1056/NEJMoa1811403
2. Bhatt DL et al. N Engl J Med. 2019;380:11-22. doi.org/10.1056/NEJMoa1812792
3. Nicholls SJ et al. JAMA. 2020;324(22):2268-2280. doi.org/10.1001/jama.2020.22258

Spot an error? Email hello@everstackhealth.com and we will correct it within 48 hours.